Zhejiang Dayang Biotech Group Co Market Cap ($314.77 Million)
Market Cap & Net Worth: Zhejiang Dayang Biotech Group Co (003017)
Zhejiang Dayang Biotech Group Co market cap. Zhejiang Dayang Biotech Group Co (SHE:003017) has a market capitalization of $314.77 Million (CN¥2.15 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #14311 globally and #4227 in its home market, demonstrating a -2.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Dayang Biotech Group Co's stock price CN¥21.34 by its total outstanding shares 100800000 (100.80 Million). Also see Zhejiang Dayang Biotech Group Co cash flow conversion for how efficiently the company converts equity into cash flow.
Zhejiang Dayang Biotech Group Co Market Cap History (2020–2026)
Zhejiang Dayang Biotech Group Co market cap history from 2020 to 2026. Data shows change from $499.65 Million to $314.77 Million (-3.94% CAGR). Check Zhejiang Dayang Biotech Group Co (003017) stock price for real-time trading data and today's change.
Zhejiang Dayang Biotech Group Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Dayang Biotech Group Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 003017 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.42x
Zhejiang Dayang Biotech Group Co's market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.41x
Zhejiang Dayang Biotech Group Co's market cap is 4.41 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $499.65 Million | $678.34 Million | $91.61 Million | 0.74x | 5.45x |
| 2021 | $409.77 Million | $783.21 Million | $70.01 Million | 0.52x | 5.85x |
| 2022 | $276.82 Million | $1.06 Billion | $80.73 Million | 0.26x | 3.43x |
| 2023 | $348.26 Million | $919.45 Million | $50.01 Million | 0.38x | 6.96x |
| 2024 | $274.65 Million | $909.96 Million | $63.75 Million | 0.30x | 4.31x |
| 2025 | $440.44 Million | $1.05 Billion | $99.85 Million | 0.42x | 4.41x |
Competitor Companies of 003017 by Market Capitalization
Companies near Zhejiang Dayang Biotech Group Co in the global market cap rankings as of November 4, 2026. Also see Zhejiang Dayang Biotech Group Co total assets for a full breakdown of the balance sheet.
Key companies related to Zhejiang Dayang Biotech Group Co by market ranking:
- BASF SE (F:BASA): Ranked #586 globally with a market cap of $45.63 Billion USD ( €39.03 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #603 globally with a market cap of $44.62 Billion USD ( €38.17 Billion EUR).
- Dow Inc (NYSE:DOW): Ranked #1063 globally with a market cap of $24.63 Billion USD.
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #1079 globally with a market cap of $24.17 Billion USD ( CN¥165.15 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #586 | BASF SE | F:BASA | $45.63 Billion | €13.20 |
| #603 | BASF SE | XETRA:BAS | $44.62 Billion | €53.55 |
| #1063 | Dow Inc | NYSE:DOW | $24.63 Billion | $34.18 |
| #1079 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $24.17 Billion | CN¥22.52 |
Market Capitalization of Zhejiang Dayang Biotech Group Co (2020–2026)
Market capitalization of Zhejiang Dayang Biotech Group Co from 2020 to today. Between 2020 and today, Zhejiang Dayang Biotech Group Co's market cap moved from $499.65 Million to $ 314.77 Million, with a yearly change of -3.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥314.77 Million | -28.53% |
| 2025 | CN¥440.44 Million | +60.37% |
| 2024 | CN¥274.65 Million | -21.14% |
| 2023 | CN¥348.26 Million | +25.81% |
| 2022 | CN¥276.82 Million | -32.45% |
| 2021 | CN¥409.77 Million | -17.99% |
| 2020 | CN¥499.65 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Zhejiang Dayang Biotech Group Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $314.77 Million USD |
| MoneyControl | $314.77 Million USD |
| MarketWatch | $314.77 Million USD |
| marketcap.company | $314.77 Million USD |
| Reuters | $314.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Dayang Biotech Group Co
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium bicarbonate, ammonium chloride, manufactures and sales bicarbonate food and feed additives; veterinary drugs; potassium bicarbonate; and ammonium chloride. It also provides 2-chloro-6-fluorobenzoic acid, fluoro… Read more